Recruiting studies

Memory loss and mild Alzheimer’s
  1. Home
  2. Our studies
  3. Memory loss and mild Alzheimer’s

Memory loss and mild Alzheimer’s

Study

Men and Women
Smokers and Non smokers
60 to 85 years old
22 visits over 32 months
Tablet
Sherbrooke
26$ to 286$ per visit
Up to 2912$

Alzheimer’s Disease - Take Action on Cognitive Decline

 

Alzheimer's disease is an age-related neurodegenerative disease characterized by a progressive decline in cognitive function and the ability to perform activities of daily living that ultimately lead to death from complications of the disease.

Pathological features of the disease identified include neuronal loss, particularly pronounced in areas of the brain important for cognition, such as the hippocampus and temporal cortex.

The present clinical study aims to demonstrate that the medication currently used for this research slows cognitive and functional decline, and to assess the safety of chronic administration, in participants with symptomatic Alzheimer's disease.

To participate, you must:

  • Be between 60 and 85 years old
  • Have a gradual change in memory function reported by the participant or informant for more than 6 months.

You will be given reimbursement for study-related expenses when you participate in the clinical study and you will be surrounded by a medical team throughout the process.

I want to apply to this clinical study

Sherbrooke

For more information, contact us at 819 346-2887 (Sherbrooke) or at 1-844-739-3439 (toll free), or fill the online form.

The study process in pictures

Explanation

Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.

Meeting

Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.

Decision

Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.

Tests

Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.

Departure

Step 5 | If you are eligible, you may then begin a clinical study with us.